Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments

BACKGROUND: To evaluate the benefits of SARS-CoV-2 vaccination in cancer patients it is relevant to understand the adaptive immune response elicited after vaccination. Patients affected by hematologic malignancies are frequently immune-compromised and show a decreased seroconversion rate compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfannes, Roald, Pierzchalski, Arkadiusz, Maddalon, Ambra, Simion, Alexandra, Zouboulis, Christos C., Behre, Gerhard, Zenclussen, Ana Claudia, Westphal, Sabine, Fest, Stefan, Herberth, Gunda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177659/
https://www.ncbi.nlm.nih.gov/pubmed/37187728
http://dx.doi.org/10.3389/fimmu.2023.1087996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177659/
https://www.ncbi.nlm.nih.gov/pubmed/37187728
http://dx.doi.org/10.3389/fimmu.2023.1087996

Ejemplares similares